XML 28 R9.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating activities      
Net income $ 3,575 $ 68,742 $ 38,117
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 8,320 8,080 6,664
Impairment of capitalized software development costs 516 574 169
Stock-based compensation expense 44,144 46,924 6,991
Common stock warrant expense 8,762 29,292 13,177
Credit loss expense 1,963 1,215 828
Loss on debt extinguishment 0 9,686 0
Amortization of debt discount and issuance costs 152 1,055 3,310
Change in fair value of convertible notes derivative liability 0 3,085 5,000
Deferred income taxes 3,146 (53,622) 0
Other 30 28 62
Changes in assets and liabilities:      
Accounts receivable 10,237 4,397 (105,709)
Other current and long-term assets 3,444 (24,640) 1,180
Accounts payable 355 (911) 1,818
Due to third-party publishers 13,619 20,827 60,724
Accrued expenses (1,253) (6,360) 5,196
Deferred revenue (2,029) 2,336 (423)
User redemption liability (8,485) (10,525) (13,881)
Other current and long-term liabilities 8,778 15,734 (507)
Net cash provided by operating activities 95,274 115,917 22,716
Investing activities      
Additions to property and equipment (20,293) (871) (548)
Additions to capitalized software development costs (14,010) (9,330) (7,680)
Maturities of short-term investments 0 0 27,900
Net cash (used in) provided by investing activities (34,303) (10,201) 19,672
Financing activities      
Proceeds from exercise of stock options 9,124 13,478 3,049
Debt issuance costs (2) (808) (12)
Proceeds from initial public offering, net 0 206,692 0
Purchase of treasury stock (232,971) (31,321) 0
Taxes paid related to net share settlement of equity awards (3,420) (3,319) 0
Deferred offering costs 0 (6,037) (652)
Proceeds from employee stock purchase plan 3,220 2,788 0
Other financing activities 0 (90) 0
Net cash (used in) provided by financing activities (224,049) 181,383 2,385
Net change in cash, cash equivalents, and restricted cash (163,078) 287,099 44,773
Cash, cash equivalents, and restricted cash, beginning of period 349,690 62,591 17,818
Cash, cash equivalents, and restricted cash, end of period 186,612 349,690 62,591
Supplemental disclosures of cash flow information      
Interest paid 247 2,583 5,491
Income taxes paid 5,147 13,208 4,110
Supplemental disclosures of non-cash investing and financing activities      
Share repurchases in accounts payable and accrued expenses 3,283 0 0
Stock-based compensation included in capitalized software development costs 1,120 421 414
Conversion of convertible debt into Class A common stock 0 103,584 0
Property and equipment in accounts payable and accrued expenses $ 2,946 $ 175 $ 209